The endoplasmic reticulum (ER) unfolded protein response (UPR) restores equilibrium to the ER, but prolonged expression of the UPR effector CHOP (GADD153) is cytotoxic. We found that CHOP expression induced by ER stress was suppressed by prior engagement of toll-like receptor (TLR) 3 or 4 through a TRIF-dependent pathway. TLR engagement did not suppress phosphorylation of PERK or eIF-2α, which are upstream of CHOP, but phospho-eIF-2α failed to promote translation of the CHOP activator ATF4. In mice subjected to systemic ER stress, pretreatment with low dose lipopolysaccharide (LPS), a TLR4 ligand, suppressed CHOP expression and apoptosis in splenic macrophages, renal tubule cells and hepatocytes, and prevented renal dysfunction and hepatosteatosis. This protective effect of LPS did not occur in Trif -/ -mice or in wildtype mice in which CHOP expression was genetically restored. Thus, TRIF-mediated signals from TLRs selectively attenuate translational activation of ATF4 and its downstream target gene CHOP. We speculate that this mechanism evolved to promote survival of TLR-expressing cells that experience prolonged levels of physiological ER stress in the course of the host response to invading pathogens.
1
. The UPR is initiated by activation of three molecules, PERK, IRE1α and ATF6. Activation of PERK leads to the phosphorylation of eIF-2α, which suppresses translation initiation of most cellular proteins but promotes translation initiation of ATF4, leading to transcription of the ATF4 downstream target CHOP (GADD153). In most circumstances, the three known transducers of UPR are regulated by similar cues and are thus coordinately activated 1 . An exception to this rule is pathologically prolonged ER stress, which occurs in a variety of disease processes where sustained PERK-CHOP signalling leads to apoptosis [2] [3] [4] [5] [6] [7] [8] . However, there are situations in normal physiology in which ER stress is prolonged, and we wondered how the cell prevents prolonged expression of pro-apoptotic CHOP under these conditions. For example, the IRE1α-XBP-1 pathway is activated during B cell differentiation in plasma cells 9 , but CHOP expression is low, and evidence suggests this low level of CHOP expression promotes B cell survival 10 .
Another situation in which prolonged ER stress occurs is during the response of the host to invasive organisms, as exemplified by exposure of cells to LPS, which activates TLR4 (A002296) signalling through the MyD88-Mal and TRIF-TRAM adaptors. This activation results in the production of inflammatory cytokines and antimicrobial proteins 11 . Prolonged ER stress occurs during LPS-TLR4 signalling 12, 13 , which probably arises from a marked increase in protein synthesis. Thus, we wondered whether CHOP expression in this setting is also suppressed.
To test the hypothesis that TLR4 signalling might suppress CHOP expression during a sustained UPR response, macrophages were pretreated in the absence or presence of a low dose of LPS that does not induce ER stress and then subjected to conditions of ER stress, including accumulation of lipoprotein-derived cholesterol 4, 14 , tunicamycin, a glycosylation inhibitor 15 , azetidine, a proline analogue 16 and arsenite, an inducer of cellular oxidant stress 17 . LPS pretreatment markedly decreased levels of CHOP protein (Fig. 1a) , CHOP mRNA ( Supplementary Information, Fig. S1a ) and ATF4 protein (Fig. 1b) . In a time course experiment (see explanation in legend to Supplementary  Information, Fig. S1b ), we found that the ability of LPS to suppress CHOP in ER-stressed macrophages is persistent and occurs regardless of whether LPS is added before or at the same time as the ER stressor.
Despite marked suppression of CHOP, LPS pretreatment of macrophages or MEFs did not significantly suppress tunicamycin-induced phospho-PERK or phospho-eIF-2α ( Fig. 1c, d ; Supplementary Information, S2b), which are upstream of CHOP. The eIF-2α phosphatase GADD34, which is regulated by CHOP and also by other processes 18, 19 , was not markedly suppressed by LPS pretreatment ( Supplementary  Information, Fig. S1d ), indicating that lack of phospho-eIF-2α suppression is not simply caused by a decrease in GADD34. LPS pretreatment also did not suppress the other two branches of the UPR, as indicated by similar XBP-1 splicing and cleaved nuclear ATF6 in LPS-pretreated cells, compared with ER-stressed cells (Fig. 1e, f) . Phosphorylation of IRE1α, which is upstream of XBP-1 splicing, and expression of three chaperones downstream of XBP-1-grp78, calnexin, and calreticulin-were also not suppressed by LPS pretreatment (data not shown). Thus, LPS suppresses ATF4 and CHOP in a highly selective manner.
To determine whether suppression of CHOP was coupled to ER stress per se, we used a genetically altered MEF-based model described previously 20 . In this model, PERK is replaced by a cytoplasmic protein (FV2E-PERK), which dimerizes on exposure to cell-permeant AP20187 (AP), leading to eIF-2α phosphorylation in the absence of ER stress. We found that AP-induced CHOP was suppressed by pretreatment with LPS (Fig. 1g) .
Thus, the ability of LPS pretreatment to suppress CHOP is uncoupled to ER stress per se, consistent with the finding that the process is not mediated by suppression of the PERK-phospho-eIF-2α pathway. Moreover, the pathway cannot be explained by 'preconditioning' , whereupon cells pre-exposed to modest ER stress become relatively resistant to subsequent UPR activation 6 , as ER stress is not induced by 1 ng ml -1 LPS in macrophages ( Fig. 1a ; Supplementary Information, Fig. S2 ), and preconditioning, in contrast to the pathway described here, is associated with suppression of all three branches of the UPR 6 , including phospho-eIF-2α (Fig. 1h) . As expected 21, 22 , ATF4 mRNA did not change with tunicamycin treatment and we found that ATF4 mRNA levels were not significantly altered by pretreatment with LPS ( Supplementary Information, Fig. S1c ). Despite stable levels of ATF4 mRNA, the incorporation of 35 S-methionine-cysteine ) and then treated for 2 h with or without AP20187 (AP, 2 nM) to activate FV2E-PERK. Lysates were immunoblotted for CHOP, phospho-eIF-2α and β-actin. The CHOP:β-actin densitometry ratios for Con, AP and LPS-AP were 0.44, 0.74 and 0.44, respectively; the phosphoeIF-2α:β-actin ratios were 0.44, 0.88 and 0.97. RNA was assayed for CHOP mRNA by QT-PCR (*P <0.01, compared with other values). (h) Macrophages were pre-incubated for 24 h with the indicated concentrations of tunicamycin and then treated for 16 h with tunicamycin (1 μg ml -1 ). Cell extracts were immunoblotted for CHOP, phospho-eIF2α, and β-actin. (i) Macrophages treated similarly to those in c were pulse-labelled with 35 S-methionine-cysteine for 20 min, followed by control (IgG) or anti-ATF4 immunoprecipitation. Autoradiograms of SDS-PAGE gels are shown. (j) Proteins from cells labelled as above were precipitated with ice-cold TCA and counted for 35 S cpm. For bar graphs in panels g and j, data are presented as mean ± s.e.m., n = 3. *P <0.01, compared with Con; **P <0.001, compared with TN.
into ATF4 protein after a 20-min labelling period was markedly reduced when exposure to tunicamycin was preceded by LPS (Fig. 1i) . Given the brevity of the labelling period, this observation suggests that LPS affects rates of ATF4 translation and not protein stability. An effect of LPS on ER stress-mediated translational control is further supported by the observation that LPS pretreatment interfered with suppression of global protein synthesis, which is normally observed after induction of ER stress (Fig. 1j) . The global protein data also indicate that the decrease in 35 S-labelled ATF4 in the LPS-tunicamycin-treated cells cannot be explained by dilution of the radiolabelled charged tRNA(Met) pool. These data suggest that LPS pretreated cells become 'resistant' to the translational effects of phospho-eIF-2α, which both prevents ATF4-CHOP expression and maintains global protein synthesis.
We used peritoneal macrophages from a series of gene-targeted mice to map the TLR pathway involved in suppression of CHOP by LPS pretreatment. The marked suppression of CHOP by LPS in wild-type macrophages was almost completely absent in Tlr4 -/-and Trif -/-macrophages, but not in Myd88 -/-macrophages ( Fig. 2a-c) . Similar data were observed with macrophages from Tram -/-mice (data not shown).
Furthermore, pretreatment of macrophages with the TLR3 (A002295) ligand poly(I:C), which only uses TRIF signalling 11 , markedly suppressed tunicamycin-induced CHOP expression (Fig. 2d) .
A major signal transducer downstream of the TRIF branch is IRF3, which subsequently induces expression of type 1 interferons 11 . However, macrophages from Irf3 -/-mice showed normal suppression of tunicamycin-induced CHOP by LPS or poly(I:C) pretreatment (Fig. 2e , upper blots). Moreover, immunoneutralization of interferon-α and interferon-β had no effect on CHOP suppression (data not shown). Consistent with this finding, siRNA-mediated silencing of TANKbinding kinase 1 (TBK1), a kinase that mediates TRIF signalling 11 , did not block suppression of CHOP by LPS (data not shown). Two other signal transducers that can be downstream of TRIF during TLR3 or TLR4 signalling are IRF5 and IRF7 [23] [24] [25] . LPS, and especially poly(I:C), were unable to fully suppress tunicamycin-induced CHOP in macrophages deficient in either of these molecules (Fig. 2e , lower blots). In summary, LPS and poly(I:C) suppress CHOP in ER-stressed macrophages through a TLR-TRIF pathway that probably involves IRF5 and IRF7 but not IRF3. To test this pathway in vivo, wild-type and Trif -/-mice were pretreated with of LPS (80 μg kg -1 day -1 ), which did not cause any observable adverse effects in the mice, or vehicle control for two consecutive days and then exposed to an intraperitoneal injection of tunicamycin for 12 h to induce systemic ER stress 2 . CHOP was induced in macrophages by tunicamycin treatment, and LPS suppressed this induction in wild-type but not Trif -/-mice (Fig. 3a) . Importantly, LPS pretreatment did not suppress phospho-eIF-2α (Fig. 3b) , consistent with the mechanism elucidated in cultured cells (above). Apoptosis, as assessed by TUNEL staining, followed the same pattern as CHOP, namely, induction by ER stress and suppression by LPS in wild-type but not Trif -/-mice (Fig. 3c) . Sepsis, as modelled by treatment with high dose LPS, leads to prolonged ER stress 12, 13 . Successful host defence would probably call for prolonged UPR activation to handle increased protein load but suppression of prolonged CHOP expression. The pathway described here might enable high dose LPS to act as both an activator of the UPR and a selective suppressor of CHOP. To test this idea, wild-type and Trif -/-mice were injected with LPS (5 mg kg ) intraperitoneally and killed 48 h later. (a, b) Kidney extracts were assayed for CHOP, phospho-eIF-2α, and total eIF-2α expression, and kidney sections were immunostained for CHOP (CHOP IHC). The average phosphoeIF-2α:total eIF-2α densitometry ratios for the Con, TN, and LPS-TN groups were 0.26, 0.59, and 0.56, respectively (a). Arrows depict CHOP-positive nuclei in renal tubular cells (b). Scale bar, 10 μm. (c) Serum creatinine levels and urine albumin levels (normalized to urine creatinine) were determined for all groups of mice. *P <0.01, compared with Con; **P <0.001, compared with TN. (d-f) The livers were assayed for CHOP, phospho-eIF-2α, and total eIF-2α expression; Oil Red O staining; and triglyceride and cholesterol mass. The average phospho-eIF-2α:total eIF-2α densitometry ratios for the Con, TN, and LPS-TN groups were 0.59, 0.64, and 0.86, respectively (e). Scale bar, 10 μm. *P <0.01, compared with Con; **P <0.001, compared with TN (f). (g) Treatment of mice with high dose LPS activates renal PERK, but CHOP is suppressed and renal function is preserved in a TRIF-dependent manner. Wild-type or Trif -/-mice were injected intraperitoneally with 5 mg kg -1 LPS or vehicle control. Seven hours later, the kidneys were assayed for phospho-PERK and CHOP by immunoblot and for CHOP mRNA by RT-QPCR. *P <0.01, compared with Con. Serum creatinine levels were measured at the indicated times after LPS treatment. *P <0.01, compared with wild-type mice. For all graphs, data are presented as mean ± s.e.m., n = 3. resulted in only a slight increase in CHOP expression in wild-type mice at the 30-min time-point, and it was suppressed thereafter (Fig. 3d, left graph) . By contrast, CHOP expression rose substantially after 30 min in the splenic macrophages of Trif -/-mice. Despite the lack of increase in CHOP expression in wild-type splenic macrophages, phospho-eIF-2α was markedly increased at both 30 min and 3 h (Fig. 3d, middle graph) , consistent with the ability of high dose LPS to trigger the UPR and indicative of selective suppression of CHOP. The later rise in CHOP in Trif -/-but not wild-type splenic macrophages correlated with a sharp rise in apoptosis (Fig. 3d, right graph) . Thus, during UPR activation by high dose LPS in vivo, splenic macrophage CHOP ) intraperitoneally and killed 48 h later. Kidneys were collected and subjected to immunoblot for CHOP and β-actin, and serum was assayed for creatinine concentration (a, b). *P <0.01, compared with Con; the two values for the Chop -/-mice were not significantly different. Livers were collected and subjected to immunoblot for CHOP and β-actin, and extracts were assayed for triglyceride mass (c, d). *P <0.001, compared with Con; **P <0.01, compared with wild-type TN value. (e-j) Mice were injected intravenously with LPS (80 μg kg ) intraperitoneally and killed 48 h later. Expression of renal CHOP and serum creatinine levels were determined (e, f). *P <0.01, compared with Con and AdGFP. Renal tubule sections were stained for TUNEL or activated caspase-3 and quantified for percent-positive cells (g, h). *P <0.001, compared with Con; **P = 0.01, compared with control and <0.001, compared with AdGFP. Liver extracts were assayed for CHOP expression and triglyceride mass (i, j). *P <0.01, compared with Con and AdGFP. For all graphs, data are presented as mean ± s.e.m., n = 3. Scale bars, 20 μm (g, h).
is selectively suppressed in a TRIF-dependent manner, and this response is associated with protection against splenic macrophage apoptosis.
The renal proximal tubular epithelium responds to infectious insults through a TLR4-induced inflammatory response 26 . Moreover, the renal tubular epithelium is highly responsive to ER stress inducers, which is associated with renal dysfunction in a number of renal diseases 2, 27 . We verified that both CHOP and phospho-eIF-2α were increased in the kidneys of tunicamycin-treated mice, with CHOP expression primarily in tubular cells (Fig. 4a, b) . Pretreatment with low dose LPS markedly suppressed CHOP but not phospho-eIF-2α in the kidneys of wild-type mice, and CHOP suppression did not occur in Trif -/-mice (Fig. 4a) . Two measures of renal function, serum creatinine and urine albumin:creatinine ratio, were abnormal in tunicamycin-treated wild-type mice but not in mice pretreated with LPS, and this protective effect of LPS was not seen in Trif -/-mice (Fig. 4c) . Hepatocytes also express TLR4 and respond to LPS 28, 29 , and are susceptible to ER stress-induced pathology, including CHOP-induced hepatic steatosis 30, 31 . In tunicamycin-treated mice, CHOP was suppressed by low dose LPS pretreatment in wild-type but not Trif -/-liver (Fig. 4d) . There was considerable basal expression of phospho-eIF-2α and it increased only slightly in the tunicamycin-treated mice, but it was not suppressed-and was actually slightly increased-by LPS (Fig. 4d) . Livers from the tunicamycin-treated mice contained vacuolated hepatocytes that stained with Oil Red O, indicative of hepatosteatosis, which was suppressed by low dose LPS pretreatment (Fig. 4e) . Consistent with these data, triglyceride and cholesterol content were higher in the livers of tunicamycin-treated mice, compared with control mice, and LPS pretreatment partially restored lipid levels to the control values in wild-type but not Trif -/-mice (Fig. 4f) . We re-examined the kidney findings in the model of ER stress induced by high dose LPS described above. Wild-type and Trif -/-mice were injected with LPS (5 mg kg -1 ), followed by examination of renal CHOP expression and renal function. LPS treatment resulted in phosphorylation of PERK in both wild-type and Trif -/-kidneys (Fig. 4g) . CHOP was not induced by LPS treatment in wild-type kidney, but was robust in the Trif -/-kidneys. Most importantly, serum creatinine did not rise in wild-type mice for as long as 7 h after treatment with high dose LPS, but serum creatinine did increase in the TRIF-deficient mice. To test the concept that the protective effect of LPS in tunicamycin-treated mice is caused by CHOP suppression, we compared tunicamycin-induced renal dysfunction and hepatosteatosis in wild-type, compared with Chop -/-mice. As above, tunicamycin treatment increased renal CHOP expression and serum creatinine, which was not seen in Chop -/-mice (Fig. 5a, b) . Similarly, hepatic CHOP induction in tunicamycin-treated mice was associated with an increase in hepatic triglyceride content, which was abrogated in Chop -/-mice (Fig. 5c, d ). We next used CHOP cDNA-containing adenovirus (adeno-CHOP) to restore CHOP expression in LPSpretreated, ER-stressed mice to a level similar to that in mice not pretreated with LPS (Fig. 5e) . Restoration of CHOP prevented LPSmediated protection from renal dysfunction and tubular apoptosis ( Fig. 5f-h) . Treatment of non-ER-stressed mice with adeno-CHOP led to a 2-3-fold increase renal tubular apoptosis (data not shown). Adeno-CHOP also blocked LPS-mediated protection from hepatosteatosis in ER-stressed mice (Fig. 5i, j) . Thus, suppression of CHOP expression is the mechanism by which low dose LPS prevents ER stress-induced renal tubular cell apoptosis, renal dysfunction and hepatosteatosis.
The coordinate expression of all three branches of the UPR contributes to adaptation to physiological stressors that would otherwise perturb the equilibrium of various ER functions 1 . The CHOP segment of the PERK branch presents a special situation in this process, because prolonged expression of CHOP triggers cell death [2] [3] [4] [5] [6] [7] . Therefore, in cases of prolonged physiological ER stress, such as occurs during processes that entail a high level of protein synthesis, prolonged CHOP expression would not be desirable and, indeed, CHOP has been found to be suppressed under these conditions 10 (data herein). Several mechanisms have been proposed, including dephosphorylation of phospho-eIF-2α by CHOP-induced GADD34 (ref. 1), inhibition of the kinase domains of PKR and PERK by ATF6-induced P58
IPK (refs 32, 33) , and suppression of all UPR branches by prior low levels of ER stress 6 . However, the lack of suppression of P-PERK and phospho-eIF-2α by LPS indicates that none of these mechanisms is responsible for ATF4-CHOP suppression by TLR-TRIF signalling. Indeed, the pathway described herein may uniquely allow cells to benefit from intact PERK activity 34 while avoiding the detrimental effects of CHOP.
The crucial role of TLRs in innate immunity has led us to speculate that the pathway revealed herein may protect cells from physiologically prolonged ER stress associated with host defence. Using high dose LPS as a model of sepsis, we showed that disabling the TLR-CHOP suppression pathway by TRIF deficiency resulted in detrimental effects in splenic macrophages and the kidney. However, other in vivo models will be needed to further expand the possible situations in which TLR-TRIF signalling is crucial to prevent the detrimental effects of prolonged ER stress. Moreover, once the downstream signalling pathways are further elucidated, other non-TLR pathways leading to suppression of ATF4 translation may be revealed, which in turn might suggest additional situations in which the fundamental principles of this pathway come into play in vivo.
A key mechanistic question that arises from our findings is how TLR-TRIF signalling suppresses ATF4 translation but not global translation in the face of phosphorylated eIF-2α. For phospho-eIF-2α to influence rates of translation initiation, the phosphorylation event must be sensed by eIF-2B, the GTP-exchange factor for eIF-2. Thus, it is possible that TLR-TRIF signalling may modulate such sensing by affecting known (that is, eIF-2B or eIF-2 components) or yet to be discovered components. Interference with this mechanism could account for the effects of LPS on both the normally observed upregulation of ATF4 and the global downregulation of protein synthesis.
In summary, the data presented in this report reveal a TLR-UPR cross-talk pathway in which pre-exposure of cells to activators of TLR-TRIF signalling selectively suppresses ATF4-CHOP expression in the setting of prolonged ER stress. This mechanism could uniquely enable the beneficial aspects of prolonged physiological ER stress without the detrimental effects of prolonged CHOP expression. Failure of this adaptive pathway may help explain diseases driven by excess CHOP expression 3, 5, 8 , and selective targeting of this pathway may suggest new strategies to kill cancer cells that have adapted to prolonged ER stress 35 . Figure S1 LPS suppresses tunicamycin-induced CHOP mRNA and protein, but not ATF4 mRNA or GADD34. a CHOP mRNA was quantified by RT-QPCR in untreated macrophages (Con); macrophages treated for 7 h with 1 µg/ml tunicamycin; macrophages pre-treated for 24 h with 1 ng/ml LPS prior to tunicamycin treatment; or in macrophages treated for 24 h with LPS alone. *, P < 0.02 vs. Con; **, P < 0.008 vs. TN. b In the upper blot, macrophages were exposed to one dose of 1 ng/ml LPS at time = 0 h and then treated with 1 µg/ml tunicamycin at time = 24 h. At 3, 7, 10, and 16 h after the tunicamycin treatment, cell extracts were immunoblotted for CHOP and β-actin. In the lower blot, macrophages were exposed to one dose of 1 ng/ml LPS at time = 0 h, 24 h, or both 0 and 24 h. The cells then treated with 1 µg/ml tunicamycin at time = 24 h, and at time= 48 h, cell extracts were immunoblotted for CHOP and β-actin. c Total RNA was extracted and subjected to quantitative RT-PCR using primers for ATF4 and a control mRNA, cyclophilin A. The data are expressed as the level of ATF4 mRNA relative to that of cyclophilin A. None of the values were statistically different from each other. d GADD34 and CHOP expression were determined in untreated macrophages (Con); macrophages treated for 3 or 7 h with 1 µg/ml tunicamycin; or macrophages pre-treated for 24 h with 1 ng/ml LPS prior to tunicamycin treatment. For the graphs in a and c, data are presented as mean ± S.E.M., n = 3. Macrophages were incubated for 12 or 24 h in medium alone or in medium containing 1 ng/ml LPS. In those cases where no basal signal was seen, a 12-h incubation with 1 µg/ml tunicamycin (TUN) was used as a positive control. Whole-cell extracts were assayed by immunoblot for P-PERK, P-eIF2a, CHOP, and β-actin (loading control); RNA was assayed by RT-PCR for unspliced and spliced XBP-1; and nuclear extracts were assayed by immunoblot for cleaved ATF6 and nucleophosmin (nuclear loading control). As noted in the text and seen in Fig. 1H , macrophages demonstrate basal cleaved ATF6, which is shown here to diminish after 24 h in culture. However, at neither timepoint was ATF6 increased above control by LPS. b Macrophages were pre-incubated for 24 h in the absence or presence of 1 ng/ml LPS and then treated for 7 h with 1 µg/ ml tunicamycin where indicated. Cell extracts were immunoblotted using antibodies against phospho-PERK, phospho-eIF-2α, total eIF-2α, and β-actin. 
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